We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Articles

Results 1 to 3 of 3
Most popular |Most recent


Stem cell news - EPO revokes ‘Brüstle’ patent and new CJEU referral on the patentability of parthenotes

United Kingdom, European Union, Germany - June 4 2013 As previously reported in this newsletter (1), the question of the patentability of technology based on the use of human embryonic stem cells (hESC)...

Pharmaceutical patenting in India - Novartis loses Glivec patent battle

India - June 4 2013 The Supreme Court of India recently rejected Novartis AG's attempt to win patent protection for an updated version of its cancer drug Glivec. This...

Tom Pagdin.

EPO revokes patent in the "Brüstle" case

European Union - April 17 2013 In October 2011, The Court of Justice of the European Union (CJEU) issued its decision in Brüstle v Greenpeace (C-3410), which relates to the...